BCRX logo

BioCryst Pharmaceuticals (BCRX) Non current assets

Annual non current assets:

$68.45M+$47.46M(+226.06%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BCRX annual long term assets is $68.45 million, with the most recent change of +$47.46 million (+226.06%) on December 31, 2024.
  • During the last 3 years, BCRX annual non current assets has risen by +$46.44 million (+210.93%).
  • BCRX annual non current assets is now at all-time high.

Performance

BCRX Non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

quarterly non current assets:

$70.07M+$1.62M(+2.36%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BCRX quarterly long term assets is $70.07 million, with the most recent change of +$1.62 million (+2.36%) on March 31, 2025.
  • Over the past year, BCRX quarterly non current assets has increased by +$49.28 million (+237.00%).
  • BCRX quarterly non current assets is now -35.69% below its all-time high of $108.96 million, reached on June 30, 2024.

Performance

BCRX quarterly non current assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Non current assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

BCRX Non current assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+226.1%+237.0%
3 y3 years+210.9%+337.8%
5 y5 years+525.9%+532.3%

BCRX Non current assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+226.1%-35.7%+346.7%
5 y5-yearat high+527.1%-35.7%+557.3%
alltimeall timeat high+4789.4%-35.7%+5739.2%

BCRX Non current assets History

DateAnnualQuarterly
Mar 2025
-
$70.07M(+2.4%)
Dec 2024
$421.97M(-14.9%)
$68.45M(+6.7%)
Sep 2024
-
$64.13M(-41.1%)
Jun 2024
-
$108.96M(+424.1%)
Mar 2024
-
$20.79M(-1.0%)
Dec 2023
$495.97M(-4.0%)
$20.99M(+2.6%)
Sep 2023
-
$20.46M(+8.7%)
Jun 2023
-
$18.83M(-0.1%)
Mar 2023
-
$18.85M(-43.7%)
Dec 2022
$516.50M(-8.8%)
$33.50M(-32.5%)
Sep 2022
-
$49.59M(+216.2%)
Jun 2022
-
$15.69M(-2.0%)
Mar 2022
-
$16.01M(-27.3%)
Dec 2021
$566.14M(+74.8%)
$22.02M(+69.1%)
Sep 2021
-
$13.02M(+13.4%)
Jun 2021
-
$11.48M(+7.7%)
Mar 2021
-
$10.66M(-2.3%)
Dec 2020
$323.80M(+97.0%)
$10.91M(-20.8%)
Sep 2020
-
$13.79M(+26.9%)
Jun 2020
-
$10.87M(-1.9%)
Mar 2020
-
$11.08M(+1.3%)
Dec 2019
$164.34M(+43.7%)
$10.94M(-6.5%)
Sep 2019
-
$11.70M(-7.4%)
Jun 2019
-
$12.63M(-48.9%)
Mar 2019
-
$24.69M(-24.0%)
Dec 2018
$114.35M(-8.8%)
$32.49M(-18.4%)
Sep 2018
-
$39.81M(-9.5%)
Jun 2018
-
$43.98M(-14.1%)
Mar 2018
-
$51.22M(-3.1%)
Dec 2017
$125.39M(+87.2%)
$52.87M(+227.9%)
Sep 2017
-
$16.12M(-24.1%)
Jun 2017
-
$21.25M(+32.7%)
Mar 2017
-
$16.01M(-30.0%)
Dec 2016
$66.99M(+5.0%)
$22.86M(-14.9%)
Sep 2016
-
$26.87M(-25.6%)
Jun 2016
-
$36.10M(-31.2%)
Mar 2016
-
$52.46M(-10.4%)
Dec 2015
$63.79M(-28.6%)
$58.56M(+7.5%)
Sep 2015
-
$54.45M(+26.4%)
Jun 2015
-
$43.09M(-11.2%)
Mar 2015
-
$48.50M(+2.0%)
Dec 2014
$89.34M(+112.1%)
$47.53M(+2299.3%)
Sep 2014
-
$1.98M(-46.8%)
Jun 2014
-
$3.73M(-51.3%)
Mar 2014
-
$7.66M(+13.5%)
Dec 2013
$42.12M(+0.3%)
$6.75M(+6.0%)
Sep 2013
-
$6.37M(-0.3%)
Jun 2013
-
$6.39M(-44.4%)
Mar 2013
-
$11.49M(-25.7%)
Dec 2012
$41.98M(-20.6%)
$15.46M(-11.7%)
Sep 2012
-
$17.51M(-43.8%)
Jun 2012
-
$31.17M(+14.9%)
Mar 2012
-
$27.14M(-7.5%)
Dec 2011
$52.86M(-39.5%)
$29.35M(-8.5%)
Sep 2011
-
$32.06M(+12.4%)
Jun 2011
-
$28.54M(+27.9%)
Mar 2011
-
$22.32M(+1.3%)
Dec 2010
$87.42M(-21.3%)
$22.03M(+2.0%)
Sep 2010
-
$21.59M(-40.6%)
Jun 2010
-
$36.35M(+14.1%)
Mar 2010
-
$31.86M(+2.2%)
Dec 2009
$111.02M
$31.17M(+214.8%)
DateAnnualQuarterly
Sep 2009
-
$9.90M(+36.7%)
Jun 2009
-
$7.24M(-3.1%)
Mar 2009
-
$7.47M(-22.7%)
Dec 2008
$75.02M(-18.2%)
$9.67M(-49.8%)
Sep 2008
-
$19.24M(-63.0%)
Jun 2008
-
$52.03M(+0.3%)
Mar 2008
-
$51.88M(+1.7%)
Dec 2007
$91.70M(+100.3%)
$51.01M(+2.9%)
Sep 2007
-
$49.59M(+83.7%)
Jun 2007
-
$27.00M(+30.9%)
Mar 2007
-
$20.63M(-9.1%)
Dec 2006
$45.79M(-43.5%)
$22.70M(-28.0%)
Sep 2006
-
$31.54M(+3.0%)
Jun 2006
-
$30.63M(+0.7%)
Mar 2006
-
$30.43M(+67.7%)
Dec 2005
$81.10M(+239.7%)
$18.15M(+171.9%)
Sep 2005
-
$6.67M(-30.7%)
Jun 2005
-
$9.63M(+23.8%)
Mar 2005
-
$7.78M(-9.5%)
Dec 2004
$23.87M(+15.3%)
$8.60M(-40.1%)
Sep 2004
-
$14.36M(-15.8%)
Jun 2004
-
$17.06M(+1.2%)
Mar 2004
-
$16.86M(+79.6%)
Dec 2003
$20.70M(-17.0%)
$9.39M(-22.2%)
Sep 2003
-
$12.06M(+24.8%)
Jun 2003
-
$9.66M(-35.6%)
Mar 2003
-
$15.01M(-8.3%)
Dec 2002
$24.93M(-23.1%)
$16.37M(+1.0%)
Sep 2002
-
$16.21M(-19.5%)
Jun 2002
-
$20.15M(-13.1%)
Mar 2002
-
$23.20M(-13.1%)
Dec 2001
$32.40M(+25.8%)
$26.69M(-14.5%)
Sep 2001
-
$31.22M(-3.8%)
Jun 2001
-
$32.44M(-4.5%)
Mar 2001
-
$33.98M(-24.6%)
Dec 2000
$25.76M(+4.7%)
$45.07M(-1.9%)
Sep 2000
-
$45.92M(-2.8%)
Jun 2000
-
$47.23M(-2.5%)
Mar 2000
-
$48.43M(-0.8%)
Dec 1999
$24.60M(+7.4%)
$48.80M(+662.5%)
Sep 1999
-
$6.40M(-22.9%)
Jun 1999
-
$8.30M(+13.7%)
Mar 1999
-
$7.30M(+17.7%)
Dec 1998
$22.90M(+16.2%)
$6.20M(+287.5%)
Sep 1998
-
$1.60M(-5.9%)
Jun 1998
-
$1.70M(-57.5%)
Mar 1998
-
$4.00M(-41.2%)
Dec 1997
$19.70M(-29.9%)
$6.80M(+47.8%)
Sep 1997
-
$4.60M(+12.2%)
Jun 1997
-
$4.10M(-61.7%)
Mar 1997
-
$10.70M(+18.9%)
Dec 1996
$28.10M(+140.2%)
$9.00M(+650.0%)
Sep 1996
-
$1.20M(-7.7%)
Jun 1996
-
$1.30M(0.0%)
Mar 1996
-
$1.30M(-7.1%)
Dec 1995
$11.70M(+5.4%)
$1.40M(0.0%)
Sep 1995
-
$1.40M(-6.7%)
Jun 1995
-
$1.50M(-6.3%)
Mar 1995
-
$1.60M(-5.9%)
Dec 1994
$11.10M
$1.70M(0.0%)
Sep 1994
-
$1.70M(-5.6%)
Jun 1994
-
$1.80M(-59.1%)
Mar 1994
-
$4.40M

FAQ

  • What is BioCryst Pharmaceuticals annual long term assets?
  • What is the all time high annual non current assets for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual non current assets year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly long term assets?
  • What is the all time high quarterly non current assets for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly non current assets year-on-year change?

What is BioCryst Pharmaceuticals annual long term assets?

The current annual non current assets of BCRX is $68.45M

What is the all time high annual non current assets for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual long term assets is $68.45M

What is BioCryst Pharmaceuticals annual non current assets year-on-year change?

Over the past year, BCRX annual long term assets has changed by +$47.46M (+226.06%)

What is BioCryst Pharmaceuticals quarterly long term assets?

The current quarterly non current assets of BCRX is $70.07M

What is the all time high quarterly non current assets for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly long term assets is $108.96M

What is BioCryst Pharmaceuticals quarterly non current assets year-on-year change?

Over the past year, BCRX quarterly long term assets has changed by +$49.28M (+237.00%)
On this page